CL
Christoph Lengauer
OtherActivePartner at Third Rock Ventures
Boston, United StatesFounded 2018
58
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Christoph Lengauer.
Investment Thesis & Strategy
Third Rock Ventures, with partner Christoph Lengauer, invests in various stages of biotech and pharmaceutical companies, focusing on those with disruptive technologies and the potential to address significant unmet medical needs.
Portfolio Companies
Selected investments from their portfolio of 58 companies
C
Celsius Therapeutics
Biotech · Series A, 0
M
MyoKardia
Biotech · Series B, 0
E
Edimer Pharmaceuticals
Biotech · Series A, 0
R
Revolution Medicines
Biotech · Series B, 0
T
Tango Therapeutics
Biotech · Series B, 0
N
Neon Therapeutics
Biotech · Series B, 0
T
TARIS Biomedical
Biotech · Series A, 0
N
NinePoint Medical
Healthcare · Series B, 0
A
Asher Bio
Biotech · Series A, 0
T
Thrive Earlier Detection
Healthcare · Series B, 0
S
Sesen Bio
Biotech · Series A, 0
I
Inc.
Other · Seed, 0
Frequently Asked Questions
Christoph Lengauer focuses on Seed stage investments.